Current Report Filing (8-k)
2022年5月7日 - 05:08AM
Edgar (US Regulatory)
0000731766false00007317662022-05-062022-05-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
—————————————
FORM 8-K
—————————————
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 6,
2022
—————————————
UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter)
—————————————
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware |
|
1-10864 |
|
41-1321939 |
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UnitedHealth Group Center, 9900 Bren Road East, |
Minnetonka, |
Minnesota |
55343 |
|
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (952)
936-1300
N/A
(Former name or former address, if changed since last
report.)
—————————————
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
Common Stock, $.01 par value |
|
UNH |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
☐
Emerging growth company
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
☐
Item 7.01. Regulation FD
Disclosure.
Senior leaders from UnitedHealth Group Incorporated (the "Company")
will respond to questions in an interview format, including
discussion of the Company’s strategy, market positions, recent
results and expectations for its end markets, at the Bank of
America Securities 2022 Healthcare Conference on Tuesday, May 10,
2022, beginning at 1:00 p.m., Eastern Time / 10:00 a.m., Pacific
Time.
A live audio webcast of the presentation will be made available
through the Investors page of the Company’s website at
www.unitedhealthgroup.com.
The information in this Item 7.01 shall not be deemed "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934, nor
shall it be deemed incorporated by reference in any Company filing
under the Securities Act of 1933 or the Securities Exchange Act of
1934, except as shall be expressly set forth by specific reference
in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
Date: May 6, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITEDHEALTH GROUP INCORPORATED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Kuai H. Leong |
|
|
|
|
|
|
|
|
|
Kuai H. Leong |
|
|
|
|
Assistant Secretary |
UnitedHealth (NYSE:UNH)
過去 株価チャート
から 6 2022 まで 7 2022
UnitedHealth (NYSE:UNH)
過去 株価チャート
から 7 2021 まで 7 2022
